CGI

:   CpG island

DEGs

:   differentially expressed genes

DMCs

:   DNA‐methylated CpG sites

DMRs

:   differentially methylated regions

HCC

:   hepatocellular carcinoma

TCGA

:   The Cancer Genome Atlas

Hepatocellular carcinoma (HCC) is one of the most common malignant cancers worldwide, leading to about one million deaths annually [1](#feb412433-bib-0001){ref-type="ref"}. HCC is a heterogeneous disease, and the underlying risk factors were liver cirrhosis, alcoholism, chronic hepatitis B virus, and chronic hepatitis C virus. Despite progress in therapy, 5‐year survival rates of HCC remain unfavorable [2](#feb412433-bib-0002){ref-type="ref"}. Therefore, it is urgent to deeply explore the mechanism of HCC based on a more comprehensive approach to promote the exploration of targeted therapy.

DNA methylation is a major event of epigenetic modifications which are heritable and stable. Recently, DNA methylation has been extensively investigated in cancer [3](#feb412433-bib-0003){ref-type="ref"}. Promoter hypermethylation induces the silencing or downregulation of genes especially for tumor suppressor genes, whereas global DNA hypomethylation leads to genomic instability [4](#feb412433-bib-0004){ref-type="ref"}. Emerging evidences have suggested that altered DNA methylation profiles were involved in early stage of HCC [5](#feb412433-bib-0005){ref-type="ref"}, [6](#feb412433-bib-0006){ref-type="ref"}. Holmila demonstrated that aberrant *VIM* and *FBLN1* methylation levels in cell‐free DNA were potential plasma‐based biomarkers for HCC [7](#feb412433-bib-0007){ref-type="ref"}. Nevertheless, DNA methylation alterations in HCC have not been elucidated systemically.

Previous evidences have clearly underscored the crucial role of DNA methylation in the regulation of gene expression in the process of normal development and diseases such as HCC [8](#feb412433-bib-0008){ref-type="ref"}. Despite recent advances that permit genomewide screening in the DNA methylation or mRNA expression level, the mechanisms of DNA methylation involved in the regulation of gene expression remain unclear in HCC. The TCGA database offers large‐scale and multigenomic data of over 30 human compressive insight into methylation characters of HCC, we performed differential analysis in DNA‐methylated and gene expression level based on the data from TCGA, and then, a integration analysis of DNA methylation and gene expression changes to uncover the regulatory role of DNA methylation [9](#feb412433-bib-0009){ref-type="ref"}. Finally, several crucial genes were selected to validate DNA methylation and gene expression pattern in GEO database and assessed their potential diagnosis value and the correlation with overall HCC survival. Our results may provide some clues for the regulatory role of DNA methylation in HCC.

Materials and methods {#feb412433-sec-0002}
=====================

Data collection {#feb412433-sec-0003}
---------------

The DNA methylation array data (Illumina Infinium Human Methylation 450 BeadChip), mRNA expression data (IlluminaGA_RNASeqV2.1.0.0), and the corresponding clinical information of HCC were downloaded from TCGA dataset firehose browse (<http://firebrowse.org/>). According to the corresponding clinical information, the patients with a history of other malignancy were excluded. Consequently, 361 tumor tissues and 41 corresponding adjacent normal tissues from HCC patients were included in this study. According to 361 personal clinical information and methylation data, integrative clinical‐methylation‐expression analysis was performed using R package. Clinical information includes grade, fibrosis, gender, and stage.

Identification of differentially methylated CpG sites and differentially methylated regions {#feb412433-sec-0004}
-------------------------------------------------------------------------------------------

We removed the CpG sites for which beta value was not available in more than 80% samples, and obtained 395 633 CpG sites. COHCAP package in R [10](#feb412433-bib-0010){ref-type="ref"} was used to analyze the differentially methylated CpG sites (DMCs) and differentially methylated regions (DMRs) between HCC tumor and adjacent normal tissues. Using COHCAP, methylated state and unmethylated state were set, calculating DMRs based on CpG island (CGI) level. Manhattan plot was constructed to explore the distribution of CpG sites according to false discovery rate (FDR) by qqmanpackage in R [11](#feb412433-bib-0011){ref-type="ref"}. The top 200 DMCs were used to perform hierarchical clustering analysis by R package pheatmap.

Identification of differentially expressed genes {#feb412433-sec-0005}
------------------------------------------------

Differentially expressed genes (DEGs) between tumor and normal groups were calculated by R package DEseq2 [12](#feb412433-bib-0012){ref-type="ref"}. FDR was calculated from multiple testing corrections of raw *P*‐value via the Benjamini and Hochberg method [13](#feb412433-bib-0013){ref-type="ref"}. Finally, \|log2(fold change) \| \> 2.5 and FDR \< 0.01 were set as the threshold for DEGs.

Construction of weighted comethylation network {#feb412433-sec-0006}
----------------------------------------------

After filtering CpG sites that were missing in 80% of samples or the bottom 99% variable CpG sites, we selected 7913 sites to perform WCCNA by WGCNA package in R language [14](#feb412433-bib-0014){ref-type="ref"}. The soft threshold was set as 10. The correlation analysis between eigen vectors and tumor--normal state was performed to obtain modules associated with tumor--normal status The threshold was set as\| coefficient of correlation \|\> 0.2 and *P*‐value \<0.01. Additionally, CpG sites that were mostly correlated with eigen vectors in modules were selected as hubs. Furthermore, DMC enrichment analysis of modules in comethylation network was performed by Fisher\'s exact test in R.

Integrated analysis of DNA methylation and gene expression {#feb412433-sec-0007}
----------------------------------------------------------

To explore the relationship between DNA methylation and gene expression, DMR--DEG pairs were gained in shell. Then, the correlation analysis between DMCs and DEGs was performed in R language and those with \|coefficient of correlation \| \> 0.2 and *P*‐value \<0.05 were selected as significant ones.

Genomic features and functional enrichment analysis {#feb412433-sec-0008}
---------------------------------------------------

Genomic features included CGI context and gene context. To explore the genomic features of DMC and CpG sites in modules of comethylation network, Fisher\'s exact test was performed, and those with *P*‐value \< 0.01 were considered as significant ones. To discover the function of differentially methylated DEGs and corresponding genes of CpG sites in modules, enrichment analysis was performed by GenoCodis (<http://genecodis.cnb.csic.es/analysis>) online [15](#feb412433-bib-0015){ref-type="ref"}, including Gene Ontology (GO) [16](#feb412433-bib-0016){ref-type="ref"} and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway [17](#feb412433-bib-0017){ref-type="ref"}.

Receiver operating characteristic curve of candidate genes {#feb412433-sec-0009}
----------------------------------------------------------

To assess the diagnostic value of candidate genes, receiver operating characteristic (ROC) curve was constructed by pROC package in R. Furthermore, area under the curve (AUC) was calculated to assess the performance of each gene.

Kaplan--Meier analysis of candidate genes {#feb412433-sec-0010}
-----------------------------------------

To further explore the relationship of DNA methylation or mRNA expression level of candidate genes with overall survival time of HCC, the Kaplan--Meier curve analysis was performed. A cohort of 378 HCC patients was downloaded from cBioPortal for Kaplan--Meier analysis (<http://www.cbioportal.org/>). *P* value \<0.05 was set as the cutoff of significance; Kaplan--Meier analyses were performed by survival package in R.

Validation of DNA methylation and expression level of candidate genes {#feb412433-sec-0011}
---------------------------------------------------------------------

The DNA methylation and expression levels of differentially methylated DEGs were validated through <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89852> and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45436> generated from GEO (<https://www.ncbi.nlm.nih.gov/>) database, respectively, and were analyzed by *t*‐test.

Results {#feb412433-sec-0012}
=======

The characteristics of DNA methylation pattern in HCC {#feb412433-sec-0013}
-----------------------------------------------------

To uncover the methylation profile of HCC, we obtained 227 189 DMCs with FDR \<0.0001. As is shown in Manhattan plot (Fig. [1](#feb412433-fig-0001){ref-type="fig"}), those CpG sites distributed in all chromosomes. Using the threshold of delta beta \>0.2 and FDR \<0.0001, we obtained 6510 DMCs totally, including 3903 hypermethylated and 2607 hypomethylated CpG sites (Table [S1](#feb412433-sup-0001){ref-type="supplementary-material"}). Unsupervised hierarchic clustering analysis was performed using the top 200 DMCs based on FDR rank, which showed that the tumor group was in hypermethylated state compared to the normal group (Fig. [2](#feb412433-fig-0002){ref-type="fig"}). In table [1](#feb412433-tbl-0001){ref-type="table"}, the methylation‐clinical information‐gene expression association result was obtained by setting \|correlation\|\> 0.2 and *P* \< 0.05 and integrating with the previous methylation‐gene expression. There were three clinical features including grade, fibrosis, gender which have correlation with the methylation profile.

![Manhattan plot of CpG sites of HCC. Dots above the purple are CpG sites with FDR \< 0.0001.](FEB4-8-1093-g001){#feb412433-fig-0001}

![Heat map of top 200 DMCs based on unsupervised hierarchical clustering analysis.](FEB4-8-1093-g002){#feb412433-fig-0002}

###### 

Integrative clinical‐methylation‐expression analysis

  Methsig      Clinisig               Corsig         P‐valsig   Gene     ID      Cor        *P*‐value
  ------------ ---------------------- -------------- ---------- -------- ------- ---------- -----------
  cg00347904   fibrosis_ishak_score   0.202437131    0.003212   --       --      --         --
  cg01348293   fibrosis_ishak_score   0.221786909    0.001216   --       --      --         --
  cg07254066   fibrosis_ishak_score   0.215263276    0.002383   --       --      --         --
  cg09894698   fibrosis_ishak_score   0.211324258    0.002077   --       --      --         --
  cg11536474   fibrosis_ishak_score   0.233388754    0.000652   --       --      --         --
  cg21790626   fibrosis_ishak_score   0.217589176    0.001512   --       --      --         --
  cg22399133   fibrosis_ishak_score   0.248808261    0.000271   --       --      --         --
  cg23089825   fibrosis_ishak_score   0.204733884    0.002875   --       --      --         --
  cg23817096   fibrosis_ishak_score   0.230638024    0.000758   --       --      --         --
  cg24604013   fibrosis_ishak_score   0.217258946    0.001538   --       --      --         --
  cg26010734   fibrosis_ishak_score   0.204900751    0.002852   --       --      --         --
  cg26149244   fibrosis_ishak_score   0.213574016    0.001855   --       --      --         --
  cg26477573   fibrosis_ishak_score   0.205297519    0.002797   --       --      --         --
  cg26674943   fibrosis_ishak_score   0.200968278    0.003447   ISL2     64843   0.17766    0.00029
  cg27234864   fibrosis_ishak_score   0.22383591     0.001091   IL17D    53342   0.244176   5.24E‐07
  cg10073584   gender                 ‐0.204356353   9.20E‐05   --       --      --         --
  cg01348293   grade                  0.223914016    2.01E‐05   --       --      --         --
  cg07783282   grade                  0.210945926    6.04E‐05   --       --      --         --
  cg12840719   grade                  0.202948974    0.000126   CDKN2A   1029    0.322704   2.43E‐11
  cg14175690   grade                  0.200063167    0.000148   --       --      --         --
  cg14888916   grade                  0.22304419     2.16E‐05   --       --      --         --
  cg18161327   grade                  0.202829167    0.000116   --       --      --         --
  cg22167515   grade                  0.238598548    5.32E‐06   --       --      --         --
  cg22399133   grade                  0.204467949    0.000102   --       --      --         --
  cg22524657   grade                  0.237133078    6.09E‐06   --       --      --         --
  cg25340966   grade                  0.209457787    6.82E‐05   --       --      --         --
  cg25622366   grade                  0.203148021    0.000113   OTX1     5013    0.237605   1.07E‐06
  cg27234864   grade                  0.230871433    1.08E‐05   IL17D    53342   0.244176   5.24E‐07
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To gain more robust results, the threshold was set as followings: delta beta\>0.2, FDR\<0.05, number of DMCs in each CGI ≥ 2. Consequently, 377 significant DMRs on CGI level were obtained, comprising of 359 hypermethylated DMRs and 18 hypomethylated DMRs, which also suggested that the tumor group was more hypermethylated (Table [S2](#feb412433-sup-0002){ref-type="supplementary-material"}).

In terms of genomic features enrichment, DMCs were significantly enrichment in island, shelf, shore on CGI contest level, and gene body, 1st exon, 5′UTR, TSS200, TSS1500, 3′UTR on gene contest level. Specifically, the most enrichment term was gene body (odds ratio = 2.16, 95% confidence interval = 2.06--2.26, *P*‐value = 1.62e‐237) and CGI (odds ratio = 1.97, 95% confidence interval = 1.88--2.07, *P*‐value = 1.10 e‐156).

Construction of weighted CpG site comethylated network {#feb412433-sec-0014}
------------------------------------------------------

To explore features of comethylated modules of HCC, WCCNA was performed. Consequently, one module named turquoise including 6723 CpG sites was obtained (Fig. [3](#feb412433-fig-0003){ref-type="fig"}). This module was significantly associated with tumor--normal status (coefficient value = −0.4, *P*‐value = 2.8e‐17). Enrichment analysis indicated that CpG sites in turquoise module were significantly enriched in DMCs (odds ratio=3.02, 95% confidence interval = 2.68--3.40, *P*‐value = 8.17e‐58). Unsupervised hierarchic clustering analysis showed that the top 200 CpG sites detected in turquoise module apparently clustered all samples into two groups, and the tumor group was in the hypomethylated cluster (Fig. [4](#feb412433-fig-0004){ref-type="fig"}). At the methylation‐methylation‐clinical information‐gene expression association analysis, we get no result of methylation‐clinical information.

![Visualization of the weighted gene co‐expression network analysis. The color row underneath the dendrogram shows the module assignment determined by the Dynamic Tree Cut.](FEB4-8-1093-g003){#feb412433-fig-0003}

![Heat map of top 200 CpG sites detected in turquoise module.](FEB4-8-1093-g004){#feb412433-fig-0004}

Furthermore, genomic features enrichment analysis revealed that CpG sites in turquoise module significantly enriched in gene body, 3′UTR, TSS1500, TSS200 on gene context level, and island, shore, shelf on CGI level. The most significant enrichment was in gene body (odds ratio = 6.98, 95% confidence interval = 6.64--7.34, *P*‐value = 0) and island (odds ratio = 0.52, 95% confidence interval = 0.49--0.55, *P*‐value = 2.48e‐109), respectively. Additionally, KEGG pathway enrichment analysis revealed that CpG sites in turquoise module were significantly enriched in neuroactive ligand--receptor interaction, calcium signaling pathway, olfactory transduction, pathways in cancer, basal cell carcinoma, and focal adhesion. Inturquoise module, 10 CpG sites were identified as hubs, which were significantly associated with the module.

Integrative analysis of differentially DNA‐methylated data and DEGs {#feb412433-sec-0015}
-------------------------------------------------------------------

To explore the relationship between DNA methylation and mRNA expression, we combined the two‐omics data for further analysis. In brief, 1194 significant DEGs were obtained, consisting of 1017 upregulated genes and 177 downregulated genes (Table [S3](#feb412433-sup-0003){ref-type="supplementary-material"}).

When compared with 377 DMRs on CGI level, 30 DEGs with DMRs on CGI level were obtained (Table [2](#feb412433-tbl-0002){ref-type="table"}). There were more than one DMR for *DLX5*,*TLX1*, and *ZIC4*. Moreover, after correlation analysis between DEGs and DMCs, 192 DMC--DEG pairs were obtained, including 132 positive and 60 negative pairs, and 114 DEGs were involved. Among those DEGs, 14 DEGs (*ALX3*,*B4GALNT1*,*CTHRC1*,*DLX5*,*EMX1*,*IRX3*,*OTX1*,*SIX2*,*TLX1*,*VASH2*,*ZIC2*,*ZIC4*,*ZIC5*, and *ZNF695*) exhibited changes in DNA methylation in terms of CpG sites or CpG island (CGI) level, in which *TLX1* and *ZIC4* had the most DMCs (numbers of DMCs were 12, 13).

###### 

Details of 30 DEGs with DMRs on CGI level

  CGI                         Delta beta    FDR of CGI    ID       Gene       log2(FC)      FDR of gene
  --------------------------- ------------- ------------- -------- ---------- ------------- -------------
  chr3:147108511‐147111703    0.224353665   1.5995E‐06    84107    ZIC4       3.901520122   1.55E‐16
  chr13:100620241‐100624348   0.224353665   5.06208E‐06   85416    ZIC5       5.929956425   8.56E‐39
  chr11:69517840‐69519929     0.224353665   3.55624E‐05   9965     FGF19      2.45740705    0.00000131
  chr8:104383409‐104384109    0.224353665   3.72024E‐05   115908   CTHRC1     3.796266642   2.08E‐32
  chr8:140714585‐140718259    0.224353665   0.000309591   51305    KCNK9      5.66721426    6.45E‐25
  chr16:54317821‐54324604     0.224353665   0.000520355   79191    IRX3       2.504358152   9.91E‐15
  chr7:96651963‐96652246      0.224353665   0.000617559   1749     DLX5       4.182961176   1.58E‐15
  chr3:147126988‐147128999    0.224353665   0.001253668   84107    ZIC4       3.901520122   1.55E‐16
  chr10:102893660‐102895059   0.224353665   0.001305997   3195     TLX1       2.904875821   3.86E‐23
  chr2:176986424‐176988291    0.224353665   0.001896195   3235     HOXD9      4.320750438   4.74E‐36
  chr7:27212416‐27214396      0.224353665   0.002180964   3206     HOXA10     5.28757278    2.37E‐38
  chr12:58021294‐58022037     0.224353665   0.002855985   2583     B4GALNT1   4.392090591   3.69E‐41
  chr1:213123647‐213125092    0.224353665   0.003566154   79805    VASH2      2.326558587   5.91E‐17
  chr10:102896342‐102896665   0.224353665   0.003643552   3195     TLX1       2.904875821   3.86E‐23
  chr2:176993479‐176995557    0.224353665   0.003882799   3234     HOXD8      2.887553258   1.13E‐24
  chr15:45421236‐45422394     0.224353665   0.004107949   53905    DUOX1      2.642074122   1.68E‐19
  chr2:47796923‐47799166      0.224353665   0.004506572   56660    KCNK12     2.455005376   0.0000154
  chr7:96650221‐96651551      0.224353665   0.005157053   1749     DLX5       4.182961176   1.58E‐15
  chr7:27225050‐27225629      0.224353665   0.006805565   3207     HOXA11     4.638619017   9.44E‐16
  chr7:27225050‐27225629      0.224353665   0.006805565   221883   HOXA11AS   4.73472334    3.43E‐14
  chr2:73151200‐73152060      0.224353665   0.009829895   2016     EMX1       4.020354566   2.61E‐23
  chr2:177014948‐177015214    0.224353665   0.011476792   3233     HOXD4      5.026837451   2.51E‐24
  chr13:100637112‐100637472   0.224353665   0.012182794   7546     ZIC2       6.225385763   7.87E‐69
  chr7:96653467‐96654199      0.224353665   0.012301547   1749     DLX5       4.182961176   1.58E‐15
  chr1:110610265‐110613303    0.224353665   0.013184706   257      ALX3       2.320617164   7.53E‐17
  chr19:1465206‐1471241       0.224353665   0.013184706   10297    APC2       2.150526877   1.89E‐19
  chr2:63281034‐63281347      0.224353665   0.015046186   5013     OTX1       4.429178371   3.03E‐29
  chr1:247170868‐247171434    0.224353665   0.016182017   57116    ZNF695     4.01893511    1.45E‐16
  chr4:13543562‐13546494      0.224353665   0.016772702   579      NKX3‐2     3.81853949    8.22E‐13
  chr7:99774733‐99775583      0.224353665   0.019685191   221914   GPC2       2.101347247   1.64E‐12
  chr2:26624603‐26625057      0.224353665   0.021209748   92749    C2orf39    2.084461753   0.00000113
  chr8:145555342‐145562310    0.224353665   0.022921866   83482    SCRT1      2.8778414     0.000000436
  chr10:102891010‐102891794   0.224353665   0.024156614   3195     TLX1       2.904875821   3.86E‐23
  chr2:45235511‐45237792      0.224353665   0.033680379   10736    SIX2       5.21721399    9.13E‐29
  chr3:40428651‐40429015      0.224353665   0.047131506   956      ENTPD3     2.022142345   0.0000393
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In particular, the CpG sites of six DEGs (*SIX2*,*VASH2*,*IL17D*,*TLX1*,*OTX1*, and *LRAT*) involved in DMC--DEG pairs were among CpG sites in turquoise module. Among them, *SIX2*,*VASH2*,*IL17D*,*TLX1*, and *OTX1* were upregulated and hypermethylated. *LRAT* was downregulated and hypermethylated.

Validation of several crucial genes in other HCC cohorts from GEO database {#feb412433-sec-0016}
--------------------------------------------------------------------------

Based on the above bioinformatics analysis, eight genes (*CTHRC1*,*ZIC4*,*SIX2*,*VASH2*,*IL17D*,*TLX1*,*OTX1*, and *LART*), for which DNA‐methylated status was correlated with their gene expression, were selected for further analysis. To confirm the change in these genes in DNA methylation and gene expression level among HCC patients in other cohorts, <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89852> (a dataset presenting DNA methylation data of 74 samples, HCC = 37, normal = 37) and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45436> (a dataset presenting gene expression data of 134 samples, HCC = 93, normal = 41) were used, respectively. The DNA methylation and expression level of the selected eight genes were also significantly changed in the <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89852> and <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45436> datasets, which was highly consistent with our integrated analysis (Fig. [5](#feb412433-fig-0005){ref-type="fig"}A,B).

![The validation of the methylation and expression levels of candidate genes in HCC tissues compared with nontumor tissues based on GEO database. (A) The methylation level of candidate genes. (B) The expression level of candidate genes.](FEB4-8-1093-g005){#feb412433-fig-0005}

Assessment of the potential use of several crucial genes as diagnostic markers of HCC {#feb412433-sec-0017}
-------------------------------------------------------------------------------------

To evaluate their power as diagnostic biomarkers for HCC, we calculated their sensitivity and specificity using ROC curve analysis. For DNA‐methylated patterns of *CTHRC1*,*ZIC4*,*SIX2*,*VASH2*,*IL17D*,*TLX1*,*OTX1*, and *LART*, the AUC was all more than 0.7, with that of *OTX1* showing the most AUC (0.985) (1.000 specificity and 0.973 sensitivity). For gene expression level pattern of the eight genes, the AUC of *CTHRC1* (0.872), *SIX2* (0.896), *VASH2* (0.822), *TLX1* (0.842), *OTX1* (0.880), and *LART* (0.966) was all more than 0.8 (Fig. [6](#feb412433-fig-0006){ref-type="fig"}), with that of *LART* showing the most AUC (0.966) (0.900 specificity and 0.951 sensitivity).

![The discriminatory ability of the candidate genes between HCC tissues and adjacent nontumor tissues with ROC curve.](FEB4-8-1093-g006){#feb412433-fig-0006}

Overall survival analysis by Kaplan--Meier curves in HCC patients {#feb412433-sec-0018}
-----------------------------------------------------------------

The correlation between alter of *CTHRC1*,*ZIC4*,*SIX2*,*VASH2*,*IL17D*,*TLX1*,*OTX1*,*LART* in DNA methylated or gene expression level and HCC survival was analyzed through Kaplan--Meier curves. Among them, DNA‐hypomethylated status of *CTHRC1* (*P* = 0.0356) and *IL17D* (*P* = 0.0324) and DNA‐hypermethylated status of *VASH2* (*P* = 6.28E‐5) were significantly associated with poor survival of HCC. Additionally, the upregulation of *CTHRC1* was significantly associated with poor survival of HCC (Fig. [7](#feb412433-fig-0007){ref-type="fig"}).

![Kaplan--Meier survival curves show the correlation between methylation and expression levels of candidate genes and the overall survival time of HCC.](FEB4-8-1093-g007){#feb412433-fig-0007}

Discussion {#feb412433-sec-0019}
==========

In our study, we characterized DNA methylation profile of HCC by combining the module in comethylated network. Our results showed that HCC tumor group was hypermethylated compared with matched adjacent tissue. CGI is normally unmethylated [18](#feb412433-bib-0018){ref-type="ref"}, but our results showed that DMRs were all hypermethylated based on CGI level, indicating that the hypermethylated CGI may affect the expression of corresponding genes. Interestingly, in the DMR--DEG pairs, all the DEGs were hypermethylated and upregulated. Moreover, 69.7% (92 of 132) DMC--DEG pairs were significantly positively correlated.

Moreover, genomic features enrichment analysis indicated that DMCs were significantly enriched in gene body and differentially methylated CGIs in DMR--DEG pairs were all located in gene body. It is well known that CGI hypermethylation in promoter of tumor suppressor genes can drive downregulation of the corresponding genes. This is a classic methylation regulatory pattern in cancer [19](#feb412433-bib-0019){ref-type="ref"}. Ju Dong Yang [20](#feb412433-bib-0020){ref-type="ref"} found potential novel oncogenes (*PSRC1*,*MRE11A*,*MYO1E*), tumor suppressor genes (*CFH*,*MYRIP*), implicated in hepatocarcino‐genesis that may be regulated by CpG site methylation, and affect prognosis after resection for HCC. David A. Wheeler [21](#feb412433-bib-0021){ref-type="ref"} found significantly mutated genes, including *LZTR1*,*EEF1A1*,*SF3B1*, and *SMARCA4*, a p53 target gene expression signature correlating with poor survival. Potential therapeutic targets for which inhibitors exist include WNT signaling, *MDM4*,*MET*,*VEGFA*,*MCL1*,*IDH1*,*TERT*, and immune checkpoint proteins CTLA‐4, PD‐1, and PD‐L1. Aberrant DNA methylation in gene body has not been elucidated clearly. In bladder and colon cancer, hypermethylated CpG‐rich regions along with altered expression were detected in gene body of *PAX6* [22](#feb412433-bib-0022){ref-type="ref"}. Expressed genes were hypermethylated in active X chromosome regions compared with the corresponding silenced genes [23](#feb412433-bib-0023){ref-type="ref"}. Yang *et al*. [24](#feb412433-bib-0024){ref-type="ref"} demonstrated that the hypermethylation status in gene body promoted corresponding gene expression.So hypermethylated CGI in gene body along with upregulated gene expression may provide another DNA methylation regulatory pattern in HCC.

In WCCN, CpG sites in turquoise module were negatively correlated with tumor--normal status, and the unsupervised hierarchical clustering analysis of above CpG sites suggested a hypermethylation status of normal group. This could provide us a methylation characteristic of HCC in a systematical view. The CpG sites enriched in gene body, CGI, and DMCs suggested that there were also some common traits between differential methylation and WCCN analysis.

Moreover, a series of potentially epigenetic regulated genes were identified. *CTHRC1* (collagen triple helix repeat containing‐1), an extracellular matrix‐related secreted glycoprotein, was ubiquitously upregulated in many cancer types. For instance, it has been reported that *CTHRC1* was upregulated by promoter demethylation in gastric cancer [25](#feb412433-bib-0025){ref-type="ref"}. In our present study, *CTHRC1* was hypermethylated at CGI level along with downregulated expression. The methylation level of *CTHRC1* acted as a protective factor in HCC, whereas a contrary trend was observed for the expression of *CTHRC1* in our analysis. *CTHRC1* played an important role in attenuating fibrosis in hepatic fibrosis [26](#feb412433-bib-0026){ref-type="ref"}. Tameda *et al*. showed that knocking down of *CTHRC1* can suppress cell proliferation and motility in HCC cells. Moreover, the protein of CTHRC1 was significantly overexpressed in poorly differentiated HCC [27](#feb412433-bib-0027){ref-type="ref"}. In addition, CTHRC1 activated Wnt/PCP signaling pathway, which promoted cervical cell migration, invasion, and epithelial‐to‐mesenchymal transition (EMT) in renal cell carcinoma and glioblastoma cells [28](#feb412433-bib-0028){ref-type="ref"}, [29](#feb412433-bib-0029){ref-type="ref"}, [30](#feb412433-bib-0030){ref-type="ref"}. Herein, we give additional evidence that upregulation of CTHRC1 may be regulated by aberrant methylation in HCC.

As one member of the zinc finger of the cerebellum family, Zic family member 4 (*ZIC4*) was hypermethylated and was involved in lymph node in oral cancer [31](#feb412433-bib-0031){ref-type="ref"}. *ZIC4* was also associated with progression to muscle‐invasive disease in bladder cancer [32](#feb412433-bib-0032){ref-type="ref"}. In addition, orthodenticle homeobox 1 (*OTX1*) was upregulated and associated with high stage of colorectal cancer [33](#feb412433-bib-0033){ref-type="ref"}. Silencing of *OTX1* suppressed the proliferation and migration by promoting cell cycle arrested in HCC [34](#feb412433-bib-0034){ref-type="ref"}. Herein, *ZIC4* and *OTX1* were all hypermethylated on CGI level and upregulated, implying that DNA methylation alteration may play important roles in HCC.

Conclusion {#feb412433-sec-0020}
==========

Briefly, this integrated analysis of genomewide DNA methylation and gene expression data identified a group of novel gene signatures (*ALX3*,*B4GALNT1*,*CTHRC1*,*DLX5*,*EMX1*,*IRX3*,*OTX1*,*SIX2*,*TLX1*,*VASH2*,*ZIC2*,*ZIC4*,*ZIC5*, and *ZNF695*), which may be regulated by DNA methylation in HCC. Our further analysis of *CTHRC1*,*ZIC4*,*SIX2*,*VASH2*,*IL17D*,*TLX1*,*OTX1*, and *LART* showed the potential use of some genes as diagnostic or prognostic biomarkers.
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